Mineralys Therapeutics grants inducement equity awards to new hires under 2025 plan

PUBT · 1d ago
Mineralys Therapeutics grants inducement equity awards to new hires under 2025 plan
  • Mineralys Therapeutics granted inducement equity awards to two new non-executive employees under its 2025 Employment Inducement Incentive Award Plan.
  • Stock options covered 14,880 shares granted July 17, 2026, then 27,920 shares granted July 20, 2026.
  • Restricted stock units covered 11,160 shares granted July 17, 2026, then 20,940 shares granted July 20, 2026.
  • Options vest over four years from July 13, 2026, then July 20, 2026, with 25% after one year, then monthly.
  • RSUs vest over four years from the same commencement dates, with 25% vesting on each anniversary.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607271601PRIMZONEFULLFEED9798626) on July 27, 2026, and is solely responsible for the information contained therein.